Safety and efficacy of radiotherapy/chemoradiotherapy combined with immune checkpoint inhibitors for non-small cell lung cancer: A systematic review and meta …
J Wu, T Ni, R Deng, Y Li, Q Zhong, F Tang… - Frontiers in …, 2023 - frontiersin.org
Background It is now widely accepted that radiotherapy (RT) can provoke a systemic
immune response, which gives a strong rationale for the combination of RT and immune …
immune response, which gives a strong rationale for the combination of RT and immune …
Clinical evidence for synergy between immunotherapy and radiotherapy (SITAR)
S Gill, AK Nowak, S Bowyer, R Endersby… - Journal of Medical …, 2022 - Wiley Online Library
Previous preclinical and clinical trials have shown promising antitumour activity and toxicity
profile when employing the 'Synergy between Immunotherapy and Radiotherapy'(SITAR) …
profile when employing the 'Synergy between Immunotherapy and Radiotherapy'(SITAR) …
Radiotherapy and immunotherapy: the power of the teamwork for the treatment of NSCLC
M Bassanelli, S Ramella, M Zeuli… - Anticancer research, 2022 - ar.iiarjournals.org
Immune checkpoint inhibitors (ICPi) targeting programmed cell death 1 (PD-1)/programmed
cell death ligand-1 (PD-L1) have revolutionized the treatment of patients with advanced non …
cell death ligand-1 (PD-L1) have revolutionized the treatment of patients with advanced non …
The abscopal effect: inducing immunogenicity in the treatment of brain metastases secondary to lung cancer and melanoma
Purpose The phenomenon of radiation therapy (RT) causing regression of targeted lesions
as well as lesions outside of the radiation field is known as the abscopal effect and is …
as well as lesions outside of the radiation field is known as the abscopal effect and is …
Targeting programmed cell death protein 1 (PD-1) for treatment of non-small-cell lung carcinoma (NSCLC); the recent advances
T Dehghani, A Shahrjerdi, MS Kahrizi… - … -Research and Practice, 2023 - Elsevier
The immune system uses various immune checkpoint axes to adjust responses, support
homeostasis, and deter self-reactivity and autoimmunity. Nevertheless, non-small-cell lung …
homeostasis, and deter self-reactivity and autoimmunity. Nevertheless, non-small-cell lung …
[PDF][PDF] 非小细胞肺癌放疗联合免疫治疗相关进展
张捷， 常莉， 王丽， 李文辉 - 肿瘤, 2022 - tumorsci.org
肺癌是死亡率最高的癌症类型, 许多患者确诊时已失去手术机会. 晚期非小细胞肺癌(non-small
cell lung cancer, NSCLC) 的预后差, 放疗和化疗是主要的治疗手段. 随着免疫检查点抑制剂 …
cell lung cancer, NSCLC) 的预后差, 放疗和化疗是主要的治疗手段. 随着免疫检查点抑制剂 …
Evaluation safety and efficacy of immune checkpoint blockers (ICB) and radiotherapy combination versus ICB in non‐small cell lung cancer patients with recurrence or …
Y Zeng, L Zhang, Y Liang, X Zhang, L Li… - Cancer …, 2023 - Wiley Online Library
Background Currently, immune checkpoint blockers (ICB) and radiotherapy (RT)
combination therapy is broadly applied in non‐small cell lung cancer (NSCLC) patients …
combination therapy is broadly applied in non‐small cell lung cancer (NSCLC) patients …
[HTML][HTML] Global research landscape and trends of cancer radiotherapy plus immunotherapy: A bibliometric analysis
Y Liu, X Jiang, Y Wu, H Yu - Heliyon, 2024 - cell.com
The aim of this study was to present current research trends on the synergistic use of
radiotherapy and immunotherapy (IRT) for cancer treatment. On March 1, 2023, we …
radiotherapy and immunotherapy (IRT) for cancer treatment. On March 1, 2023, we …
[HTML][HTML] 放疗联合免疫治疗在非小细胞肺癌中的研究进展
王泽宁， 祁艳娟 - Journal of Clinical Personalized Medicine, 2024 - hanspub.org
肺癌(lung cancer, LC) 是全球最常见的癌症之一, 也是全球癌症相关死亡的主要原因,
其中约80% 的病例为非小细胞肺癌(non-small-cell lung cancer, NSCLC). 在过去十年中 …
其中约80% 的病例为非小细胞肺癌(non-small-cell lung cancer, NSCLC). 在过去十年中 …
Radiation‑induced enterocolitis after combination therapy with palliative radiotherapy and immune checkpoint inhibitors in patients with metastatic lung cancer
K Makita, Y Hamamoto, H Kanzaki… - Experimental and …, 2022 - spandidos-publications.com
The impact of immune checkpoint inhibitors (ICIs) on radiation‑induced enterocolitis (RIE)
after palliative radiotherapy (PRT) to the bowel has remained to be fully investigated. The …
after palliative radiotherapy (PRT) to the bowel has remained to be fully investigated. The …